States » NorthPosted at: Oct 4 2026 6:48PM


Major anamoly found in medicine prices at hospital pharmacies in UP by FSDA

Lucknow, Oct 4 (UNI) A big gap has emerged between the purchase rate of medicines available in hospitals and the maximum retail price (MRP) printed on the pack.
In the larger interest of providing safe drugs, the Uttar Pradesh Food Safety and Drug Administration (UPFSDA) is inspecting pharmacies of medical colleges and private hospitals. During the inspection, a comparative study of the purchase rate and MRP of medicines available in these pharmacies was also conducted.
Of the data collected from 214 hospital pharmacies across the state, 130 medicines were analyzed, of which 36 have an MRP that is far more than 10 times the pharmacy's purchase price. In some medicines, this gap was recorded at about 67 times. Notably, these include many injectable medicines used in serious infections, ICU and other complex medical conditions.
In the study, the pharmacy purchase rate of Polymyxin-B Injection (GUFIPOL 500,000 Unit), used in serious bacterial infections, was recorded at only ₹74.09, while the MRP on the pack was ₹4,980.94.
That is, the MRP was about 67 times the purchase price. For GUFIPOL 5 Lac of the same medicine, the purchase price was recorded at ₹90 and the MRP at ₹4,528.10. In this case, the MRP was found to be about 50 times the purchase rate. Thus, even among different brands/packs of the same medicine, a notable gap between purchase price and MRP was seen.
The purchase price of Terlipressin Injection (Terlitech 10 ml), used in certain medical conditions related to serious liver disease, was recorded in the study at ₹56, while its MRP was ₹3,050. Thus, the MRP was about 54 times the purchase price. For another brand of the same medicine, TERONIM 10 ML, the purchase price was recorded at ₹56 and the MRP at ₹2,600. Here, a gap of about 46 times was found between purchase price and MRP.
Powerful antibiotics used in treating drug-resistant serious infections are also included in the study. The purchase price of Colistimethate Sodium 4.5 MIU was recorded at ₹210, while its MRP was ₹9,702.31. That is, the MRP was about 46 times the purchase price. Similarly, for Tigecycline Injection 50 mg, the purchase price of ₹154.54 compared with an MRP of ₹7,110.47. Here too, a gap of about 46 times emerged between MRP and purchase rate. These figures found in the inspection are significant because these are not medicines in the category of ordinary OTC drugs, but medicines used in hospitals to treat serious and complex infections.
The study also compared data across different brands of the same medicine. For various brands of Meropenem 1 gm, used in treating serious bacterial infections, the ratio of purchase price to MRP was not uniform. Across its different brands, the MRP was recorded at about 5.31 times to 9.98 times the pharmacy's purchase price. That is, even in a medicine of the same strength, the gap between purchase rate and MRP changes as the brand changes.
A big gap was also recorded across different brands of Caspofungin 70 mg, used in treating serious fungal infections. One brand's purchase price was ₹800, while its MRP was recorded at ₹21,230. That is, the MRP was about 26.5 times the purchase price.
For another brand of the same medicine, the purchase price was ₹897.75 and the MRP was recorded at ₹19,892. In this case, the MRP was about 22 times the purchase price. These figures show that even across different brands of a medicine of the same strength, the ratio of purchase rate to MRP is not uniform.
In expensive cancer and life-saving medicines, although the ratio of purchase price to MRP is lower compared to some other injections, the gap in rupees per unit was recorded as quite large. For example, the purchase price of Bevacizumab 400 mg was ₹7,541.10, while its MRP was recorded at ₹69,995.
That is, a gap of ₹62,453.90 emerged between purchase price and MRP. The purchase price of Inonza 1 mg is ₹2,07,504, while the MRP is ₹3,02,610. Meanwhile, the purchase price of Simulect 200mg inj is ₹72,700.95 and the MRP is ₹95,420. In addition, the purchase price of Keytruda 100 mg inj is ₹1,81,860 and the MRP is ₹2,16,500.
The inspection was not limited to medicines. Data on the purchase price and MRP of medical devices used in hospitals was also examined. The purchase price of one 3-way stop cock was recorded at ₹6.40, while its MRP was ₹163.
Thus, the MRP was about 25 times the purchase price. Another medical device had a purchase price of ₹20.95, while its MRP was recorded at ₹500. Here too, a gap of about 24 times emerged between purchase price and MRP.
The wide gap between purchase rate and MRP in the data collected from hospital pharmacies also raises questions about the pricing and trade margin model of medicines. The departmental analysis is also looking into why the MRP on the pack is recorded as many times higher even though medicines are supplied to hospitals at very low rates.
There is a suspicion that, to maintain room for higher trade margins and discounts, the MRP is in some cases kept much higher than the actual purchase rate. In such a situation, a hospital can show the patient a big discount on the MRP, while its actual purchase price is far lower than that. In this arrangement, there is ample room for margin for both the manufacturer and the hospital, but how much of the real benefit reaches the patient is the key question. UNI MBD SAS
Tags: #Major anamoly found in medicine prices at hospital pharmacies in UP by FSDA
More News

HP: BJP will form govt in 2027, Shrikant Sharma

04 Oct 2026 | 7:44 PM

Hamirpur(HP), Oct 4 (UNI) BJP in-charge of Himachal Pradesh, Shrikant Sharma today expressed optimism that a change was imminent in the Congress-ruled state and the party would return to power in the 2027 assembly elections.
He said this during a meeting of the state office bearers of the party held at Tipper village today.

see more..

Ex-Haryana Speaker Kuldeep Sharma targets Hooda, urges Congress to abandon CM-face politics

04 Oct 2026 | 7:40 PM

Panchkula, Oct 4 (UNI) Former Haryana Assembly Speaker and Congress leader Kuldeep Sharma has launched a sharp attack on former chief minister Bhupinder Singh Hooda and his son Deepender Singh Hooda, arguing that projecting individual leaders as chief ministerial candidates has hurt the party in Haryana and restricted its ability to build a broader political coalition.

see more..

Writers’ Group 'Qalamkaar' launches poetry collection 'Sun Meri Dhiye’ in Jammu

04 Oct 2026 | 7:23 PM

Jammu, Oct 4 (UNI) Qalamkaar--The Writers’ Group, Sunday launched “Sun Meri Dhiye”, a collection of Dogri poems by noted writer Anuradha Atri here at the Press Club Jammu.

see more..

Sewa Jyoti Yatra to take spirit of service to every J&K district: Sat

04 Oct 2026 | 7:21 PM

Jammu, Oct 4 (UNI) Jammu and Kashmir BJP chief Sat Sharma Sunday said that the spirit of “Sewa” will reach every corner of Jammu and Kashmir through the Sewa Jyoti Yatra, as the BJP prepares to organize the Yatra across all 20 administrative districts on October 7, making it a people-centric expression of service, nationalism and commitment to the nation.

see more..

J&K: Protest seeking official language status to Punjab intensifies in Jammu

04 Oct 2026 | 7:16 PM

Jammu, Oct 4 (UNI) The campaign demanding official language status for Punjabi in Jammu and Kashmir intensified on the fourth day of the indefinite Morcha, as protest rallies were taken out across Jammu region.

see more..